Clinical Trial Update: Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture [Phase 3]

View source ↗

Summary

Phase 3 trial investigating parecoxib use after traumatic rib fractures and its effect on narcotic use and length of stay; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rib Fractures

Drugs mentioned

• Parecoxib (parecoxib)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Parecoxib, Rib Fractures | Phase 3 | Status: TERMINATED